Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 4688-4695, September 1, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Minnick, D. T.
Right arrow Articles by David Sedwick, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Minnick, D. T.
Right arrow Articles by David Sedwick, W.

Mutational Specificity of 1,3-Bis-(2-chloroethyl)-1-nitrosourea in a Chinese Hamster Ovary Cell Line1

Dana T. Minnick, Martina L. Veigl and W. David Sedwick2

Departments of Environmental Health Sciences [D. T. M., M. L. V., W. D. S.] and Medicine [M. L. V., W. D. S.], Ireland Cancer Center, University Hospitals, Case Western Reserve University, Cleveland, Ohio 44106

The mutational specificity of the alkylating agent 1-3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) was analyzed at the endogenous hemizygous adenine phosphoribosyl transferase gene of the Chinese hamster ovary cell line D422. A 1-h treatment of the Chinese hamster ovary cells with 50 µM BCNU resulted in a toxicity level of 62% and induced mutation at this target with a frequency of 32.1 mutants/106 survivors (6-fold above background). Analysis of 49 BCNU-induced mutants at the DNA sequence level revealed that BCNU induced primarily base substitutions. The predominant BCNU-induced mutations were G:C->T:A transversions, which comprised 51% (25 of 49) of the mutations; while G:C->A:T transitions, expected from miscoding of O6-alkylguanine, represented only 16.3% (8 of 49) of the mutants recovered. This result was not anticipated, since Chinese hamster ovary cells are deficient in O6-alkylguanine-DNA alkyltransferase, which should render them especially sensitive to O6-alkylguanine-mediated mutations. It was also notable that two "hotspots" for BCNU-induced G:C->T:A transversions were observed, which involved different surrounding DNA sequences but similar helix parameters when analyzed by an application of Calladine's Rules. Possible mechanisms for the observed BCNU-induced mutations are presented.

1 Supported in part by National Institute of Environmental Health Services Research Grant R01 ESO5540 awarded to W. D. S.; a research grant from the Cuyahoga County Unit, Ohio Division of the American Cancer Society, awarded to M. L. V.; a research grant from Glaxo, Inc., to W. D. S. and M. L. V.; and a Cancer Center core grant to the Ireland Cancer Center (P30CA43703).

2 To whom requests for reprints should be addressed, at Case Western Reserve University, Department of Medicine, Hematology/Oncology, UCRC Building 2, Suite 200, 11001 Cedar Road, Cleveland, OH 44106.

Received 2/17/92. Accepted 6/17/92.




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
M. D. Bacolod, S. P. Johnson, A. E. Pegg, M. E. Dolan, R. C. Moschel, N. S. Bullock, Q. Fang, O. M. Colvin, P. Modrich, D. D. Bigner, et al.
Brain tumor cell lines resistant to O6-benzylguanine/1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy have O6-alkylguanine-DNA alkyltransferase mutations
Mol. Cancer Ther., September 1, 2004; 3(9): 1127 - 1135.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. D. Bacolod, S. P. Johnson, F. Ali-Osman, P. Modrich, N. S. Bullock, O. M. Colvin, D. D. Bigner, and H. S. Friedman
Mechanisms of Resistance to 1,3-Bis(2-chloroethyl)-1-nitrosourea in Human Medulloblastoma and Rhabdomyosarcoma
Mol. Cancer Ther., July 1, 2002; 1(9): 727 - 736.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Inga, F.-X. Chen, P. Monti, A. Aprile, P. Campomenosi, P. Menichini, L. Ottaggio, S. Viaggi, A. Abbondandolo, B. Gold, et al.
N-(2-Chloroethyl)-N-nitrosourea Tethered to Lexitropsin Induces Minor Groove Lesions at the p53 cDNA That Are More Cytotoxic than Mutagenic
Cancer Res., February 1, 1999; 59(3): 689 - 695.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.